VP, Novel Asset Advancement

Job not on LinkedIn

🔥 0 minutes ago

Apply Now
Find Similar Remote Jobs

📊 Check your resume score for this job

Improve your chances of getting an interview by checking your resume score before you apply.

Logo of Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited

501 - 1000 employees

Founded 2015

🧬 Biotechnology

💊 Pharmaceuticals

⚕️ Healthcare Insurance

Biotechnology • Pharmaceuticals • Healthcare Insurance

Telix Pharmaceuticals Limited is a commercial-stage biopharmaceutical company dedicated to transforming the way cancer and rare diseases are diagnosed and treated. Focusing on the development and commercialization of theranostic radiopharmaceuticals, Telix utilizes targeted radiation to enhance treatment decision-making and deliver personalized therapy. With an extensive pipeline addressing areas such as prostate and kidney cancer, neuro-oncology, and musculoskeletal cancers, Telix has garnered global regulatory approvals for its lead imaging agent, Illuccix®, and is actively conducting numerous clinical trials worldwide.

📋 Description

• Serve as the executive asset owner for Telix’s CD66-targeted hematology-oncology programs, with full accountability for end-to-end asset strategy, progression, and value realization through clinical development and toward registration. • Define and continuously evolve the integrated asset strategy, including development approach, indication prioritization, target product profile, and long-range positioning aligned to enterprise portfolio priorities. • Own the integrated business case, including financial assumptions, risk-adjusted scenarios, and value inflection points, and lead executive-level recommendations on investment, prioritization, and development pathways. • Act as the primary accountable leader in executive governance forums (e.g., GET), presenting strategic options, trade-offs, and recommendations while driving enterprise decision-making and alignment. • Operate as a peer to functional Vice Presidents, leading cross-functional alignment across Clinical, Regulatory, Manufacturing, Commercial, Finance, and Quality to ensure execution of a unified and optimized development strategy. • Drive enterprise-level trade-off decisions, balancing scientific, clinical, regulatory, operational, and financial considerations to maximize probability of success and long-term asset value. • Maintain accountability for program performance, including milestone achievement, risk profile, timeline integrity, and overall readiness for key development and regulatory inflection points. • Lead identification, evaluation, and mitigation of strategic and operational risks, ensuring proactive management and clear escalation of critical issues to executive leadership. • Provide strategic financial oversight of the program, including investment planning, scenario modeling, and alignment of resource allocation with development priorities and enterprise objectives. • Ensure consistent executive-level visibility into program status, risks, opportunities, and strategic options through structured governance and performance reviews. • Influence broader portfolio strategy and lifecycle planning, including evaluation of expansion opportunities and implications for future hematology-oncology pipeline development. • Drive a high-performance cross-functional operating model, holding stakeholders accountable for delivering against shared objectives while enabling speed, clarity, and disciplined decision-making.

🎯 Requirements

• Advanced degree in life sciences, medicine, pharmacy, or related field required; PhD, MD, or PharmD preferred • 15+ years of progressive pharmaceutical or biotechnology experience, including significant experience in drug development and strategic program or asset leadership • Demonstrated experience leading complex, cross-functional development programs or assets, ideally within oncology • Proven ability to own and advance asset strategy, including business case development, development planning, and governance engagement • Strong understanding of global regulatory environments (FDA, EMA, APAC) and their impact on development strategy • Demonstrated success operating as a senior individual contributor influencing executive leadership and cross-functional decision-making • Experience presenting to and influencing executive governance bodies (e.g., executive committees, portfolio boards) • Strong financial and strategic acumen, including investment decision support, scenario planning, and risk management

🏖️ Benefits

• Competitive salaries • Annual performance-based bonuses • Equity-based incentive program • Generous vacation • Paid wellness days • Support for learning and development

Apply Now

Similar Jobs

🔥 2 hours ago

CareMetx, LLC

501 - 1000

⚕️ Healthcare Insurance

Vice President of Enterprise Transformation leading CareMetx's transformation initiatives and collaborating with executive leaders. Ensuring resources and tracking activities support business growth and patient access strategies.

🔥 14 hours ago

Fictiv

201 - 500

Vice President of Logistics & Warehousing overseeing logistics operations for MISUMI Americas. Leading strategy and operational excellence with cross-functional team collaboration.

🔥 14 hours ago

Tenet Healthcare

10,000+ employees

🧬 Biotechnology

🧘 Wellness

Vice President of Development leading M&A transactions at Tenet Healthcare. Responsible for relationships with healthcare systems and executing strategic initiatives in the ambulatory surgery space.

🇺🇸 United States – Remote

💵 $160.6k - $256.3k / year

💰 $2G Post-IPO Debt on 2022-05

⏰ Full Time

🔴 Lead

👔 Vice President

🔥 14 hours ago

Safelite

10,000+ employees

🚗 Transport

🛒 Retail

SVP leading government affairs and public policy strategy at Safelite, aligning with business goals while navigating complex regulatory landscapes.

🔥 15 hours ago

LPL Financial

5001 - 10000

💸 Finance

💳 Fintech

Business Exit Planning Associate supporting Financial Advisors with High-Net-Worth clients at LPL Financial. Collaborate on exit strategies and contribute to investment banking referrals in a dynamic environment.